Cheryl Wong Po Foo
About Cheryl Wong Po Foo
Cheryl Wong Po Foo serves as the Director of Clinical Development at Travere Therapeutics, where she has worked since 2022. With a robust background in clinical trial design and regulatory compliance, she has held various leadership positions in the biotechnology sector and has a strong academic foundation in biomedical engineering and chemistry.
Work at Travere Therapeutics
Cheryl Wong Po Foo serves as the Director of Clinical Development at Travere Therapeutics, a position she has held since 2022. In this role, she focuses on designing and overseeing clinical trials, particularly for novel cell therapies. She emphasizes compliance with FDA regulations and ICH Good Clinical Practice (GCP) standards. Her work involves building collaborative relationships with stakeholders in the regenerative medicine sector, particularly in cardiovascular and neurodegenerative therapeutic areas.
Previous Experience in Clinical Development
Prior to her current role, Cheryl worked at Astellas Gene Therapies as Director of Clinical Development from 2019 to 2022. She also held the position of Director of Clinical Science at Sangamo Therapeutics, Inc. from 2017 to 2019. Earlier in her career, she was a Senior Clinical Specialist II at BioMarin Pharmaceutical Inc. from 2016 to 2017 and served as Director of Clinical & Scientific Affairs at BioCardia Inc. from 2009 to 2016. These roles contributed to her extensive experience in designing clinical trials.
Education and Expertise
Cheryl Wong Po Foo has a strong academic background in the sciences. She completed her PhD in Chemistry, Biotechnology, and Biomedical Engineering at Tufts University from 2001 to 2006. She also studied at Stanford University, where she was a Post-doctoral Scholar in Biomedical Engineering and Materials Engineering from 2006 to 2009. Additionally, she has a BA in Chemistry and Biochemistry from Whittier College. Her education supports her expertise in clinical development and regenerative medicine.
Background in Intellectual Property and Business Development
Cheryl has a background in managing intellectual property portfolios, which complements her clinical development expertise. She has experience in business development alongside her clinical and scientific roles, allowing her to navigate the intersection of science and commercial interests effectively. This combination of skills enhances her ability to contribute to innovative therapies in the healthcare sector.
Focus on Compliance and Regulatory Standards
In her current position at Travere Therapeutics, Cheryl focuses on ensuring compliance with FDA regulations and ICH GCP guidelines. Her commitment to regulatory standards is crucial in the clinical development process, particularly in the context of novel therapies. This focus helps to ensure that clinical trials are conducted ethically and effectively, aligning with industry best practices.